This is part of the ongoing series of articles updating the evidence on current COVID-19 therapies. The rest of the series can be found here, and there is more to come. This article will cover the evidence for Interleukin-6 receptor antagonists (tocilizumab or sarilumab) in COVID-19. This is a group […]
sarilumab
1 post